Western blotting assays of Bcl-xL, Bcl-2, cleaved caspase-3, and Bax further supported the idea that PBA treatment effectively inhibited hyperglycemia-enhanced apoptosis in liver IRI (Fig. 2E). The gene discussed is CASP3; the disease is Hyperglycemia.